Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew S Moore

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Pediatric Blood & Cancer|July 30, 2024
Population-level 5-year event-free survival for children with cancer in AustraliaDanny R Youlden, Peter D Baade, Nicolas G Gottardo, et al.
Nature Communications|May 7, 2024
An interphase actin wave promotes mitochondrial content mixing and organelle homeostasisStephen M Coscia, Andrew S Moore, Cameron P Thompson, et al.
Cancer Genetics|September 24, 2023
Paediatric B lymphoblastic leukaemia with hyperdiploidy and a false-positive KMT2A fluorescence in situ hybridization resultJenna Nunn, Nandini Adayapalam, Sarbjit Riyat, et al.
Oncotarget|October 25, 2019
<i>PTEN</i> deletion drives acute myeloid leukemia resistance to MEK inhibitorsAmanda M Smith, Christine R C Zhang, Alexandre S Cristino, et al.
Nature Cell Biology|August 5, 2025
Vimentin intermediate filaments as structural and mechanical coordinators of mesenchymal cellsMing Guo, Ian Y Wong, Andrew S Moore, et al.
Oncotarget|February 21, 2020
Erratum: <i>PTEN</i> deletion drives acute myeloid leukemia resistance to MEK inhibitorsAmanda M Smith, Christine R C Zhang, Alexandre S Cristino, et al.
Acta Oncologica (Stockholm, Sweden)|August 30, 2023
Temporal changes in childhood cancer incidence and survival by stage at diagnosis in Australia, 2000-2017Danny R Youlden, Peter D Baade, A Lindsay Frazier, et al.
Plos One|June 18, 2015
EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or LeukemiaSara Charmsaz, Kirrilee Beckett, Fiona M Smith, et al.
Journal of Paediatrics and Child Health|June 11, 2011
Vincristine pharmacodynamics and pharmacogenetics in children with cancer: a limited-sampling, population modelling approachAndrew S Moore, Ross Norris, Gareth Price, et al.
Pediatric Blood & Cancer|February 26, 2019
Stage at diagnosis for children with blood cancers in Australia: Application of the Toronto Paediatric Cancer Stage Guidelines in a population-based national childhood cancer registryDanny R Youlden, Sumit Gupta, A Lindsay Frazier, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Pediatric Blood & Cancer|July 30, 2024
Population-level 5-year event-free survival for children with cancer in AustraliaDanny R Youlden, Peter D Baade, Nicolas G Gottardo, et al.
Nature Communications|May 7, 2024
An interphase actin wave promotes mitochondrial content mixing and organelle homeostasisStephen M Coscia, Andrew S Moore, Cameron P Thompson, et al.
Cancer Genetics|September 24, 2023
Paediatric B lymphoblastic leukaemia with hyperdiploidy and a false-positive KMT2A fluorescence in situ hybridization resultJenna Nunn, Nandini Adayapalam, Sarbjit Riyat, et al.
Oncotarget|October 25, 2019
<i>PTEN</i> deletion drives acute myeloid leukemia resistance to MEK inhibitorsAmanda M Smith, Christine R C Zhang, Alexandre S Cristino, et al.
Nature Cell Biology|August 5, 2025
Vimentin intermediate filaments as structural and mechanical coordinators of mesenchymal cellsMing Guo, Ian Y Wong, Andrew S Moore, et al.
Oncotarget|February 21, 2020
Erratum: <i>PTEN</i> deletion drives acute myeloid leukemia resistance to MEK inhibitorsAmanda M Smith, Christine R C Zhang, Alexandre S Cristino, et al.
Acta Oncologica (Stockholm, Sweden)|August 30, 2023
Temporal changes in childhood cancer incidence and survival by stage at diagnosis in Australia, 2000-2017Danny R Youlden, Peter D Baade, A Lindsay Frazier, et al.
Plos One|June 18, 2015
EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or LeukemiaSara Charmsaz, Kirrilee Beckett, Fiona M Smith, et al.
Journal of Paediatrics and Child Health|June 11, 2011
Vincristine pharmacodynamics and pharmacogenetics in children with cancer: a limited-sampling, population modelling approachAndrew S Moore, Ross Norris, Gareth Price, et al.
Pediatric Blood & Cancer|February 26, 2019
Stage at diagnosis for children with blood cancers in Australia: Application of the Toronto Paediatric Cancer Stage Guidelines in a population-based national childhood cancer registryDanny R Youlden, Sumit Gupta, A Lindsay Frazier, et al.
Pageof 9